Bausch Health Companies (BHC) to Release Earnings on Tuesday

Bausch Health Companies (TSE:BHCGet Rating) is scheduled to be announcing its earnings results before the market opens on Tuesday, May 10th. Analysts expect the company to announce earnings of C$1.31 per share for the quarter.

Bausch Health Companies (TSE:BHCGet Rating) last released its quarterly earnings results on Wednesday, February 23rd. The company reported C$1.61 earnings per share for the quarter, topping the consensus estimate of C$1.36 by C$0.25. The firm had revenue of C$2.77 billion for the quarter, compared to analysts’ expectations of C$2.75 billion.

Shares of TSE BHC traded down C$0.42 during midday trading on Tuesday, reaching C$23.84. The company’s stock had a trading volume of 138,593 shares, compared to its average volume of 521,987. Bausch Health Companies has a 12-month low of C$23.37 and a 12-month high of C$39.11. The stock has a market capitalization of C$8.57 billion and a P/E ratio of -7.17. The firm has a 50 day moving average price of C$28.57 and a 200-day moving average price of C$31.41. The company has a debt-to-equity ratio of 4,000.66, a current ratio of 1.08 and a quick ratio of 0.45.

Separately, Royal Bank of Canada dropped their target price on shares of Bausch Health Companies from C$34.00 to C$32.00 and set an “outperform” rating on the stock in a research note on Friday, February 25th.

In related news, Senior Officer Robert Allen Spurr sold 1,595 shares of Bausch Health Companies stock in a transaction that occurred on Thursday, April 14th. The shares were sold at an average price of C$27.96, for a total value of C$44,595.24. Following the completion of the transaction, the insider now directly owns 24,617 shares in the company, valued at approximately C$688,276.55.

Bausch Health Companies Company Profile (Get Rating)

Bausch Health Companies Inc, together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.

Featured Stories

Earnings History for Bausch Health Companies (TSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with's FREE daily email newsletter.